Schedule 13G ownership disclosure

Protalix BioTherapeutics, Inc.

Security class unavailable · CUSIP: 74365A101

Event date: 2015-04-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.3700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001546927-15-000122
Form type
SC 13G
Filer
Camber Capital Management LP
CIK
CIK 1444043
Filed
Apr 20, 2015
Reporting period
Apr 08, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub